Technology
Risk, reward and the AstraZeneca vaccine – podcast | News – The Guardian
People in the UK under 30 will be offered an alternative to the AstraZeneca vaccine because of a possible link to rare blood clots. Could the move dent confidence…
The governments Joint Committee on Vaccines and Immunisation said this week that people aged 18 to 29 who are not at high risk of Covid should have the option of an alternative jab to the AstraZeneca vaccine if one is available in their area. It follows the accumulation of evidence linking the jab to rare blood clots, although no definitive causation has yet been established. The move has sparked fears of a loss of confidence in the widely used AstraZeneca vaccine, at a point when the UK is emerging…
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
General22 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General21 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate